Abstract
About one in eleven women in the Western world develop cancer of the breast, and at least 5% of these cases are thought to result from a hereditary predisposition to the disease (1,2). Two breast cancer susceptibility (BRCA) + genes have been mapped and cloned, and mutations in these genes account for most families with four or more cases of breast cancer diagnosed before age 60. Women who inherit loss-of-function mutations in either of these genes have up to an 85% risk of breast cancer by age 70 (1). Both BRCA1 and BRCA2 are thought to be tumorsuppressor genes, as the wild-type allele of the gene is observed to be lost in tumors of heterozygous carriers. As well as breast cancer, carriers of mutations in these genes are at elevated risk of cancer of the ovary, prostate, and pancreas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rahman N, Stratton MR. Ann Rev Genet 1998; 32: 95 - 121.
Bertwistle D, Ashworth A. Curr Opin Genet Dey 1998; 8: 14 - 20.
Bertwistle D, Ashworth A. Breast Cancer Research 1999; 1: 41 - 47.
Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM. Proc Natl Acad Sci USA 1999; 96:11, 364-11, 369.
Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. Cell 1997; 88: 265 - 275.
Easton D. Breast Cancer Research 1999; 1: 14 - 17.
Lakhani S. Breast Cancer Research 1999; 1: 31 - 35.
Osin PP, Lakhani S. Breast Cancer Research 1999; 1: 36 - 40.
Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB. New Engl J Med 1999; 340: 77 - 84.
Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. J Natl Cancer Inst 1999; 91: 1475 - 1479.
Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashworth A. Nat Gen 1997; 17: 423 - 430.
Friedman LS, Thistlethwaite FC, Patel KJ, Yu VP, Lee H, Venkitaraman AR, Abel KJ, Carlton MB, Hunter SM, Colledge WH, Evans MJ, Ponder BA. Cancer Res 1998; 58: 1338 - 1343.
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Reid T, Hennighausen L, Wynshaw-Boris A, Deng CX. Nat Genet 1999; 22: 37 - 43.
Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmeuller L, Shehee R, Molinaro TA, Kim ICE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salgeuro PM, Morgan WF, Deng CX, Fornace AJ Jr. Nat Genet 1999; 23: 176 - 184.
Pao GM, Janknecht R, Ruffner H, Hunter T, Verma IM. Proc Natl Acad Sci USA 2000; 97: 1020 - 1025.
Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. Proc Natl Acad Sci USA 1998; 95: 2303 - 2306.
Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, Wang W, Kashanchi F, Shiekhattar R. Cell 2000; 102: 257 - 265.
Hu YF, Hao ZL, Li R. Genes Dey 1999; 13: 637 - 642.
Zheng L, Pan H, Shang L, Flesken-Nikitin A, Chen PL, Boyer TG, Lee WH. Mol Cell 2000; 6: 757 - 768.
Fan S, Twu NF, Wang JA, Yuan RQ, Andres J, Goldberg ID, Rosen EM. Int J Cancer1998; 75: 600 - 609.
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny U, Yu L, Hollander MC, O'Connor PM, Fornace AJ Jr, Harris CC. Proc Natl Acad Sci USA 1999; 96: 3706 - 3711.
Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH. Science 1999; 285: 747 - 750.
Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlison G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R. Mol Cell 1998; 2: 317 - 328.
Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, Sarasin A. Cancer Res 2000; 60: 5548 - 5552.
Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR. Mol Cell 1998; 1: 347 - 357.
Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Reid T, Deng CX. Mol Cell 1999; 3: 389 - 395.
Hsu LC, White RL. Proc Natl Acad Sci USA1998; 95:12, 983-12, 988.
Tutt A, Gabriel A, Bertwistle D, Connor F, Paterson H, Peacock J, Ross G, Ashworth A. Curr Biol 1999; 9: 1107 - 1110.
Griffin CS, Simpson PJ, Wilson CR, Thacker J. Nat Cell Biol 2000; 2: 757 - 761.
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Nat Gen 1998; 20: 189 - 193.
Cortez D, Wang Y, Qin J, Elledge SJ. Science 1999; 286: 1162 - 1166.
Lee J-S, Collins KM, Brown AL, Lee CH, Chung JH. Nature 2000; 404: 201 - 204.
Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. Genes Dey 2000; 14: 927 - 939.
Moynahan ME, Chiu JW, Koller BH, Jasin M. Mol Cell 1999; 4: 511 - 518.
Holt TJ. Ann NY Acad Sci 1997; 833: 34 - 41.
Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F. Science 1996; 274: 373 - 376.
Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH. Nat Med 1997; 3: 639 - 645.
Khuri FR, Nemunaitis J, Ganly I, Arsenau J, Tannock IF, Romel L, Gore M, Ironside J, MacDougall RH, Heise C, Randlev B, Gillenwater AM, Bruso P, Kaye SB, Hong WK, Kirn DH. Nat Med 2000; 6: 879 - 895.
MacLachlan TK, El-Deiry WS. Nat Med 2000; 12: 1318 - 1319.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gabriel, A., Ashworth, A. (2002). The Breast Cancer Susceptibility Genes BRCA1 and BRCA2 . In: La Thangue, N.B., Bandara, L.R. (eds) Targets for Cancer Chemotherapy. Cancer Drug Discovery and Development. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-153-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-153-4_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-263-6
Online ISBN: 978-1-59259-153-4
eBook Packages: Springer Book Archive